- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00564980
PRCT: Comparing Two Procedures for Ulno-Carpal Abutment Syndrome. (UAS)
A Randomized Prospective Study Comparing TFCC Debridement and Wafer Procedure With TFCC Debridement and Ulnar Shortening Osteotomy for Ulno-Carpal Abutment Syndrome. (UAS Study)
The purpose of this study is to evaluate two different currently accepted surgical treatments for UAS (ulnocarpal abutment syndrome).
The hypothesis is that ulnar shortening osteotomy procedure will be associated with longer surgical time and increased complication rate when compared to the wafer procedure. It is unclear as to whether there will be a difference in functional outcome between the two groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Ulnocarpal abutment syndrome (UAS) (also known as ulnar impaction syndrome, ulnocarpal impingement,ulnar carpal loading) is a common cause of ulnar sided wrist pain.
UAS results from increased loading of the ulnocarpal articulation and is usually associated with a positive ulnar variance. The increased loading of the joint can lead to degeneration and perforation of the Triangular fibrocartilage (TFC). Chondromalacic changes develop on the opposing surfaces of the lunate and triquetrum distally and the ulnar head proximally. A disruption of the lunotriquetral ligament may following with ensuing LT arthritis.
Treatment of UAS involves decompression of the pressure and impingement, or abutment of the ulnocarpal articulation. Debridement of triangular fibrocartilage complex (TFCC) tears alone in the patient with UAS may have a failure rate of as much as 25% to 30%. Good results have been reported with combined arthroscopic TFCC debridement and distal ulnar resection. 69% excellent and 32% good results have been reported with an open limited distal ulnar resection in patients with a TFCC tear and positive ulnar variance. Similar results have been reported with both ulnar shortening osteotomy and open wafer distal ulnar resections in the UAS patient. Because these treatment choices appear to yield similar relief of symptoms, determination of the optimal treatment protocol remains a point of debate.
The literature contains retrospective data comparing open wafer procedure with ulnar shortening osteotomies for the treatment of UAS. Likewise, the literature comparing arthroscopic wafer and ulnar shortening osteotomy is retrospective. However, there are, to date, no randomized prospective clinical trials comparing these types of surgery. Both types of surgery are widely accepted and the optimal treatment remains under debate. It is unclear how the techniques compare in terms of efficacy of elimination of symptoms of UAS and also in terms of relative complication rate.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
New Westminster, British Columbia, Canada, V3L 3W7
- Royal Columbian Hospital
-
Port Moody, British Columbia, Canada, V3H 3W9
- Eagle Ridge Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- persistent ulnar-sided wrist pain of a minimum of 6 months duration despite conservative management
- a positive ulnocarpal stress test
- neutral or positive ulnar variance as measured from a standard posteroanterior radiograph of the wrist
- central TFCC perforation or lunate chondral damage consistent with UAS based on arthroscopic evaluation
- arthroscopically debrided TFCC tear
Exclusion Criteria:
- absence of a TFCC tear or lunate chondral damage
- repairable TFCC tear
- severe ulnocarpal arthrosis
- pre-operative diagnosis of clinically symptomatic scapholunate ligament (SL), lunotriquetral ligament (LT), or distal radioulnar joint (DRUJ) instability
- previous forearm or wrist fracture
- history of inflammatory arthritis
- presence of other wrist pathology
- a requirement for concomitant surgery for an unrelated condition
- skeletal maturity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
Wafer Procedure
|
A dorsal approach to the distal ulna is used dividing the extensor retinaculum between the 5th and 6th compartments.
The ulnar head is exposed through a transverse capsulotomy.
Cartilage and bone are resected to result in slight negative ulnar variance based on the preoperative pronated grip view.
The ulnar styloid and TFCC attachments are preserved.
The dorsal capsule and retinaculum are repaired in separate layers.
|
|
Active Comparator: 2
Ulnar shortening osteotomy
|
A longitudinal incision of approximately 8 cm is made at the distal third of the ulna along the ulnar border of the forearm.
The interval between the flexor carpi ulnaris is used.
The ulna is exposed at its distal third preserving the periosteum.
Care is taken to protect the sensory branches of the lunar nerve.
An oblique osteotomy is performed using a reciprocating saw, removing enough bone to result is slight negative ulnar variance.
Fixation and compression at the osteotomy site is achieved using a 5 or 6 hole titanium LC-DCP plate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patient Rated Wrist Evaluation (PRWE) at baseline, 6 weeks, 3, 6 and 12 months post-operatively.
Time Frame: Subjects are followed for 12 months post-op.
|
Subjects are followed for 12 months post-op.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Wrist range of motion, grip strength, radiographs and pain Visual Analog Scale
Time Frame: Baseline, 6 weeks, 3,6 and 12 months.
|
Baseline, 6 weeks, 3,6 and 12 months.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Bertrand H Perey, MD, Royal Columbian Hospital, Eagle Ridge Hospital
Publications and helpful links
General Publications
- Palmer AK, Glisson RR, Werner FW. Ulnar variance determination. J Hand Surg Am. 1982 Jul;7(4):376-9. doi: 10.1016/s0363-5023(82)80147-0. No abstract available.
- Friedman SL, Palmer AK. The ulnar impaction syndrome. Hand Clin. 1991 May;7(2):295-310.
- Tomaino MM. The importance of the pronated grip x-ray view in evaluating ulnar variance. J Hand Surg Am. 2000 Mar;25(2):352-7. doi: 10.1053/jhsu.2000.jhsu25a0352.
- Hulsizer D, Weiss AP, Akelman E. Ulna-shortening osteotomy after failed arthroscopic debridement of the triangular fibrocartilage complex. J Hand Surg Am. 1997 Jul;22(4):694-8. doi: 10.1016/S0363-5023(97)80130-X.
- Minami A, Kato H. Ulnar shortening for triangular fibrocartilage complex tears associated with ulnar positive variance. J Hand Surg Am. 1998 Sep;23(5):904-8. doi: 10.1016/S0363-5023(98)80171-8.
- Feldon P, Terrono AL, Belsky MR. Wafer distal ulna resection for triangular fibrocartilage tears and/or ulna impaction syndrome. J Hand Surg Am. 1992 Jul;17(4):731-7. doi: 10.1016/0363-5023(92)90325-j.
- Tomaino MM, Weiser RW. Combined arthroscopic TFCC debridement and wafer resection of the distal ulna in wrists with triangular fibrocartilage complex tears and positive ulnar variance. J Hand Surg Am. 2001 Nov;26(6):1047-52. doi: 10.1053/jhsu.2001.28757.
- Constantine KJ, Tomaino MM, Herndon JH, Sotereanos DG. Comparison of ulnar shortening osteotomy and the wafer resection procedure as treatment for ulnar impaction syndrome. J Hand Surg Am. 2000 Jan;25(1):55-60. doi: 10.1053/jhsu.2000.jhsu025a0055.
- Bernstein MA, Nagle DJ, Martinez A, Stogin JM Jr, Wiedrich TA. A comparison of combined arthroscopic triangular fibrocartilage complex debridement and arthroscopic wafer distal ulna resection versus arthroscopic triangular fibrocartilage complex debridement and ulnar shortening osteotomy for ulnocarpal abutment syndrome. Arthroscopy. 2004 Apr;20(4):392-401. doi: 10.1016/j.arthro.2004.01.013.
- Milch H. Cuff resection of the ulna for malunited colles' fracture. JBJS (AM): 1941;23:311-313
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006-061
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Joint Disease
-
University of AlbertaUniversity of AlbertaCompletedTemporomandibular Degenerative Joint DiseaseCanada
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
Anderson Orthopaedic Research InstituteDePuy Orthopaedics; University of Western Ontario, CanadaCompletedNon-inflammatory Degenerative Joint DiseaseUnited States, Canada
-
DePuy InternationalActive, not recruitingNoninflammatory Degenerative Joint DiseaseUnited States, Hong Kong, Malaysia, Australia, Austria, Belgium, Canada, Germany, New Zealand, Singapore, United Kingdom, South Korea
-
Smith & Nephew Pte LtdActive, not recruitingNon-inflammatory Degenerative Joint DiseaseIndia, South Africa, South Korea, Italy
-
Stryker South PacificTerminatedNon-inflammatory Degenerative Joint DiseaseAustralia
-
Smith & Nephew, Inc.Active, not recruitingDegenerative Joint DiseaseGermany, Spain, Austria
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseNetherlands
-
Biomimedica, IncTerminatedDegenerative Joint Disease of the HipNetherlands
Clinical Trials on Wafer Procedure
-
INSYS Therapeutics IncCompletedGlioblastoma MultiformeUnited States, Canada, United Kingdom, Germany, Israel, Netherlands
-
Everfront Biotech Co., Ltd.Active, not recruitingRecurrent High Grade GliomaTaiwan
-
The Hong Kong Polytechnic UniversityThe Hong Kong Jockey Club Charities TrustCompleted
-
Armed Forces Institute of Dentistry, PakistanCompletedAnalgesia | Orthodontic Appliance ComplicationPakistan
-
Oregon State UniversityNot yet recruiting
-
Peking UniversityUnknownNeuroendocrine TumorsChina
-
University of CincinnatiEisai Inc.WithdrawnGlioblastoma MultiformeUnited States
-
Everfront Biotech Co., Ltd.Not yet recruitingRecurrent Glioblastoma, IDH-WildtypeUnited States
-
University of IowaEisai Inc.TerminatedPrimary Glioblastoma MultiformeUnited States